Reneo Pharmaceuticals, Inc. (RPHM) NASDAQ
18.20
+16.47(+952.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.20
+16.47(+952.02%)
Currency In USD
| Market Cap | 245.99M |
| Enterprise Value | 187.49M |
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0 |
| Return On Equity | 0 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -62.95M |
| Net Income | 0 |
| Diluted EPS | -4.4 |
| Total Cash | 192.11M |
| Total Cash/Share | 14.05 |
| Total Debt | 409,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.78 |
| Book Value Per Share | 13.48 |
| 52-Week Change | -76.67 |
| 52-Week High | 82.9 |
| 52-Week Low | 1.68 |
| Moving Average 50 Days | 14.92 |
| Moving Average 200 Days | 16.09 |
| Average Volume | 17,983 |
| Shares Outstanding | 3.34M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 07, 2024 |